Strides Pharma Science informs about press release

18 Jan 2023 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled ‘Stelis Biopharma’s flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

890.00 11.05 (1.26%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.